Skip to content

Subscriptions are live.

Plans

Why is $ARMP stock moving today?

Armata Pharmaceuticals, Inc. Common Stock · Biological Products, (No Diagnostic Substances)

Why is $ARMP moving today?

The likely driver

Clinical / FDA update
Armata Pharmaceuticals, Inc.: Receives $3.7 Million in Additional Non-Dilutive Funding from U.S. Department of War to Support Advancement of AP-SA02 Phase 3 Development
SEC filing · Sep 23
Price
$3.31
Move today
+0.0%
Volume vs avg
0.0x
Scanner alerts today
0
Flagged in 30 days
13
Market cap
$125M
Prev close
$3.31
Avg volume
202K

Nothing has triggered on ARMP yet in this session. Our scanner has flagged it 13 times in the last 30 days , most recently on October 13 for big percentage moves, unusual volume, which is why this page is here. See the full ARMP page for the chart and the alert history.

Earlier scanner activity on ARMP

  • Oct 13Big % mover alert
  • Oct 13Unusual volume (RVOL) alert
  • Oct 9Unusual volume (RVOL) alert
  • Oct 8Big % mover alert
  • Oct 8Unusual volume (RVOL) alert
  • Oct 2Unusual volume (RVOL) alert
  • Sep 30Unusual volume (RVOL) alert
  • Sep 23Big % mover alert
  • Sep 23Unusual volume (RVOL) alert
  • Sep 23Big % mover alert
  • Sep 23Unusual volume (RVOL) alert
  • Sep 21Big % mover alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $ARMP alerts the moment volume spikes

Our scanner flagged $ARMP 13 times in the last 30 days. Create a free account to track $ARMP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.